COVID-19: evolution of the pandemic in Russia. Report II: dynamics of the circulation of SARS-CoV-2 genetic variants

…, AS Cherkashina, SN Kuzin, EV Tivanova… - Journal of …, 2022 - microbiol.crie.ru
Background. The ongoing pandemic of the novel coronavirus infection (COVID-19) draws
attention to the significance of molecular and genetic monitoring of the SARS-CoV-2 spread …

[HTML][HTML] Patterns of the SARS-CoV-2 epidemic spread in a megacity

…, OY Shipulina, SB Yatsyshina, EV Tivanova… - Problems of …, 2020 - virusjour.crie.ru
The purpose of the study is to analyze patterns demonstrated by the COVID-19 epidemic
process in a megacity during the increase, stabilization and reduction in the incidence, and to …

Monitoring the spread of the SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) variants in the Moscow region using targeted high …

…, LY Kondrasheva, EV Tivanova… - Problems of …, 2021 - virusjour.crie.ru
Introduction. Since the outbreak of the COVID-19 pandemic caused by SARS-CoV-2 novel
coronavirus, the international community has been concerned about the emergence of …

Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts

…, AV Kalenskaya, IV Solovjeva, EV Tivanova… - Viruses, 2023 - mdpi.com
We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical
trial phase I/II of the tolerability, safety, and immunogenicity of the inactivated whole virion …

Characteristics of the COVID-19 Epidemiological Situation in the Russian Federation in 2020

…, DV Dubodelov, EV Tivanova… - Annals of the …, 2021 - vestnikramn.spr-journal.ru
Background. The COVID-19 epidemic in the Russian Federation, which began in March 2020,
caused serious damage to health of the population and led to severe economic losses. By …

Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II …

…, AV Kalenskaya, IV Solovjeva, EV Tivanova… - medRxiv, 2022 - medrxiv.org
We present the results of a randomized, double-blind, placebo-controlled, multi-center
clinical trial of the tolerability, safety, and immunogenicity of the inactivated whole virion …

Epidemiological significance of detection of SARS-CoV-2 RNA among different groups of population of Moscow and Moscow Region during the COVID-19 outbreak

…, SB Yatsyshina, EV Tivanova… - Journal of …, 2020 - microbiol.crie.ru
The Central Research Institute of Epidemiology of Rospotrebnadzor presents priority data
obtained from the largescale population PCR-based study of the changes in the rates of …

[HTML][HTML] Molecular methods for diagnosing novel coronavirus infection: comparison of loop-mediated isothermal amplification and polymerase chain reaction

…, LY Kondrasheva, EV Tivanova… - Problems of …, 2021 - virusjour.crie.ru
Introduction. Currently, the basis for molecular diagnostics of most infections is the use of
reverse transcription polymerase chain reaction (RT-PCR). Technologies based on reverse …

Effective approaches to study the genetic variability of SARS-CoV-2

…, N Borisova, A Kolesnikov, L Kondrasheva, E Tivanova… - Viruses, 2022 - mdpi.com
Significant efforts are being made in many countries around the world to respond to the
COVID-19 pandemic by developing diagnostic reagent kits, identifying infected people, …

The Role of Endothelin-I in Cardiovascular Disease in Patients With COVID-19

…, VG Akimkin, VI Zhundrikova, EV Tivanova - Available at SSRN …, 2021 - papers.ssrn.com
Elena V. Tivanova - conducting a research and investigation process, specifically performing
the experiments, or data/evidence collection. Pavel V. Chukhliaev- application of statistical, …